927 results on '"Pallansch, Mark"'
Search Results
202. Author response: Dominant drug targets suppress the emergence of antiviral resistance
203. First Confirmed Cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection in the United States, Updated Information on the Epidemiology of MERS-CoV Infection, and Guidance for the Public, Clinicians, and Public Health Authorities—May 2014
204. Hospital-Associated Outbreak of Middle East Respiratory Syndrome Coronavirus: A Serologic, Epidemiologic, and Clinical Description
205. The potential impact of expanding target age groups for polio immunization campaigns
206. Kew, O. et al. Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science 296, 356-359
207. Communicating the Molecular Epidemiology of Poliovirus by Using Geographical Information Systems for the Global Polio Eradication Initiative
208. Detection of all known parechoviruses by real-time PCR.
209. Population immunity to polioviruses in the context of a large-scale wild poliovirus type 1 outbreak in Tajikistan, 2010
210. Diversity of picornaviruses in rural Bolivia
211. Poliovirus vaccination options for achieving eradication and securing the endgame
212. Multiple Independent Emergences of Type 2 Vaccine-Derived Polioviruses during a Large Outbreak in Northern Nigeria
213. Enterovirus 71 encephalitis: a new vaccine on the horizon?
214. Naturally Acquired Picornavirus Infections in Primates at the Dhaka Zoo
215. What we are watching—five top global infectious disease threats, 2012: a perspective from CDC's Global Disease Detection Operations Center
216. Characterizing the Picornavirus Landscape among Synanthropic Nonhuman Primates in Bangladesh, 2007 to 2008
217. Characterization of outbreak response strategies and potential vaccine stockpile needs for the polio endgame.
218. Characterization of Poliovirus Variants Selected for Resistance to the Antiviral Compound V-073
219. Modeling Population Immunity to Support Efforts to End the Transmission of Live Polioviruses
220. Expert Review on Poliovirus Immunity and Transmission
221. Randomized Trial of Type 1 and Type 3 Oral Monovalent Poliovirus Vaccines in Newborns in Africa
222. Monovalent type 1 oral poliovirus vaccine among infants in India: Report of two randomized double-blind controlled clinical trials
223. Increased potency of an inactivated trivalent polio vaccine with oil-in-water emulsions
224. Economic analysis of the global polio eradication initiative
225. Parechovirus typing in clinical specimens by nested or semi-nested PCR coupled with sequencing
226. Optimal vaccine stockpile design for an eradicated disease: Application to polio
227. In Vitro Antiviral Activity of V-073 against Polioviruses
228. Shedding of Vaccine Viruses with Increased Antigenic and Genetic Divergence after Vaccination of Newborns with Monovalent Type 1 Oral Poliovirus Vaccine
229. Limited duration of vaccine poliovirus and other enterovirus excretion among human immunodeficiency virus infected children in Kenya
230. Resolving ambiguities in genetic typing of human enterovirus species C clinical isolates and identification of enterovirus 96, 99 and 102
231. Enteroviruses and Parechoviruses
232. Enterovirus‐Associated Encephalitis in the California Encephalitis Project, 1998–2005
233. Monovalent Type 1 Oral Poliovirus Vaccine in Newborns
234. Isolation of Sabin-Like Polioviruses from Wastewater in a Country Using Inactivated Polio Vaccine
235. An Outbreak of Concurrent Echovirus 30 and Coxsackievirus A1 Infections Associated with Sea Swimming among a Group of Travelers to Mexico
236. Sensitive and Broadly Reactive Reverse Transcription-PCR Assays To Detect Novel Paramyxoviruses
237. Detection of All Known Parechoviruses by Real-Time PCR
238. The Risks, Costs, and Benefits of Possible Future Global Policies for Managing Polioviruses
239. Uncertainty and Sensitivity Analyses of a Decision Analytic Model for Posteradication Polio Risk Management
240. A Large Vaccine‐Derived Poliovirus Outbreak on Madura Island—Indonesia, 2005
241. Molecular epidemiology of wild poliovirus type 1 circulation in West and Central Africa, from 1997 to 1999, using genotyping with a restriction fragment length polymorphism assay
242. Complete genome sequences for nine simian enteroviruses
243. Histopathologic, immunohistochemical, and polymerase chain reaction assays in the study of cases with fatal sporadic myocarditis
244. Molecular identification of 13 new enterovirus types, EV79–88, EV97, and EV100–101, members of the species Human Enterovirus B
245. Isolation of recombinant type 2 vaccine-derived poliovirus (VDPV) from a Nigerian child
246. Survey of poliovirus antibodies during the final stage of polio eradication in Egypt
247. Serologic Response to Inactivated Poliovirus Vaccine: A Randomized Clinical Trial Comparing 2 Vaccination Schedules in Puerto Rico
248. CDC's Early Response to a Novel Viral Disease, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), September 2012-May 2014.
249. Modeling options to manage type 1 wild poliovirus imported into Israel in 2013.
250. Polio Eradicators Use Integrated Analytical Models to Make Better Decisions.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.